| 1 |
刘宝东. 肺磨玻璃结节的诊治策略[J]. 中国肺癌杂志，2019, 22(07): 449-456.
|
| 2 |
Kudo Y, Matsubayashi J, Saji H, et al. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients[J]. Lung Cancer, 2015, 90(1): 47-54.
|
| 3 |
Yang J, Wang H, Geng C, et al. Advances in intelligent diagnosis methods for pulmonary ground-glass opacity nodules[J]. Biomed Eng Online, 2018, 17(1): 20.
|
| 4 |
Yang YQ, Lu Z, Gao J, et al. Correlations between vessel changes and the histopathologic subtypes of lung adenocarcinoma with pure ground-glass nodule on computed tomography[J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2016, 38(2): 182-186.
|
| 5 |
Wu XL, Xu QZ, Chen T, et al. Establishment and analysis of prediction model for invasive subsolid pulmonary nodules based on radiomics[J]. Zhonghua Yi Xue Za Zhi, 2022, 102(3): 209-215.
|
| 6 |
Liu Y, Sun H, Zhou F, et al. Imaging features of TSCT predict the classification of pulmonary preinvasive lesion, minimally and invasive adenocarcinoma presented as ground glass nodules[J]. Lung Cancer, 2017, 108: 192-197.
|
| 7 |
Qi L, Lu W, Yang L, et al. Qualitative and quantitative imaging features of pulmonary subsolid nodules: differentiating invasive adenocarcinoma from minimally invasive adenocarcinoma and preinvasive lesions[J]. J Thorac Dis, 2019, 11(11): 4835-4846.
|
| 8 |
Lee HW, Jin K N, Lee JK, et al. Long-term follow-up of ground-glass nodules after 5 years of stability[J]. J Thorac Oncol, 2019, 14(8): 1370-1377.
|
| 9 |
Shen L, Lin J, Wang B, et al. Computed tomography findings, clinicopathological features, genetic characteristics and prognosis of in situ and minimally invasive lung adenocarcinomas[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2019, 39(9): 1107-1112.
|
| 10 |
Wang T, Zhang T, Han X, et al. Impact of the international association for the study of lung cancer/American thoracic society/European respiratory society classification of stage IA adenocarcinoma of the lung: Correlation between computed tomography images and EGFR and KRAS gene mutations[J]. Exp Ther Med, 2015, 9(6): 2095-2103.
|
| 11 |
Nie M, Yao K, Zhu X, et al. Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma[J]. Nature Communications, 2021, 12(1): 6479.
|
| 12 |
Xiang W, Xing Y, Jiang S, et al. Morphological factors differentiating between early lung adenocarcinomas appearing as pure ground-glass nodules measuring </＝10 mm on thin-section computed tomography[J]. Cancer Imaging, 2014, 14: 33.
|
| 13 |
Kitami A, Sano F, Hayashi S, et al. Correlation between histological invasiveness and the computed tomography value in pure ground-glass nodules[J]. Surg Today, 2016, 46(5): 593-598.
|
| 14 |
Marx A, Chan JK, Coindre JM, et al. The 2015 World Health Organization Classification of tumors of the thymus: Continuity and changes[J]. J Thorac Oncol, 2015, 10(10): 1383-1395.
|
| 15 |
沈 丹，江德鹏，蒋幼凡. 未吸烟人群慢性阻塞性肺疾病与肺癌危险关系的系统评价[J]. 重庆医科大学学报，2016, 41(4): 360-363.
|
| 16 |
Selamat SA, Galler JS, Joshi AD, et al. DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma[J]. PLoS One, 2011, 6(6): e21443.
|
| 17 |
Kerr KM, Galler JS, Hagen JA, et al. The role of DNA methylation in the development and progression of lung adenocarcinoma[J]. Dis Markers, 2007, 23(1-2): 5-30.
|
| 18 |
Selamat SA, Galler JS, Joshi AD, et al. DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma[J]. PLoS One, 2011, 6(6): e21443.
|
| 19 |
Lahn M, Su C, Li S, et al. Expression levels of protein kinase C-alpha in non-small-cell lung cancer[J]. Clin Lung Cancer, 2004, 6(3): 184-189.
|
| 20 |
Yamada G, Murata M, Takasawa A, et al. Increased expressions of claudin 4 and 7 in atypical adenomatous hyperplasia and adenocarcinoma of the lung[J]. Med Mol Morphol, 2016, 49(3): 163-169.
|
| 21 |
Ilie M, Long E, Hofman V, et al. Diagnostic value of immunohistochemistry for the detection of the BRAF mutation in primary lung adenocarcinoma Caucasian patients[J]. Ann Oncol, 2013, 24(3): 742-748.
|
| 22 |
Zhou QJ, Zheng ZC, Zhu YQ, et al. Tumor invasiveness defined by IASLC/ATS/ERS classification of ground-glass nodules can be predicted by quantitative CT parameters[J]. J Thorac Dis, 2017, 9(5): 1190-1200.
|
| 23 |
Sun K, Xie H, Zhao J, et al. A clinicopathological study of lung adenocarcinomas with pure ground-glass opacity >3 cm on high-resolution computed tomography[J]. Eur Radiol, 2022, 32(1): 174-183.
|
| 24 |
Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification[J]. J Thorac Oncol, 2015, 10(9): 1243-1260.
|
| 25 |
Belinsky SA, Snow SS, Nikula K J, et al. Aberrant CpG island methylation of the p16(INK4a) and estrogen receptor genes in rat lung tumors induced by particulate carcinogens[J]. Carcinogenesis, 2002, 23(2): 335-339.
|
| 26 |
Xu X, Li N, Zhao R, et al. Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ[J]. J Cancer Res Clin Oncol, 2017, 143(12): 2447-2453.
|
| 27 |
Kimura K, Matsumoto S, Harada T, et al. ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target[J]. Cancer Sci, 2020, 111(3): 951-961.
|
| 28 |
Shin DH, Kim SH, Choi M, et al. Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1[J]. Oncogene, 2022, 41(2): 280-292.
|
| 29 |
Kim EY, Cha YJ, Lee SH, et al. Early lung carcinogenesis and tumor microenvironment observed by single-cell transcriptome analysis[J]. Transl Oncol, 2022, 15(1): 101277.
|
| 30 |
Lu T, Yang X, Shi Y, et al. Single-cell transcriptome atlas of lung adenocarcinoma featured with ground glass nodules[J]. Cell Discovery, 2020, 6: 69.
|
| 31 |
Braile M, Marcella S, Cristinziano L, et al. VEGF-A in cardiomyocytes and heart diseases[J]. Int J Mol Sci, 2020, 21(15): 5294.
|
| 32 |
Bergers G, Hanahan D. Modes of resistance to anti-angiogenic therapy[J]. Nat Rev Cancer, 2008, 8(8): 592-603.
|
| 33 |
Liu Y, Sun H, Zhou F, et al. Imaging features of TSCT predict the classification of pulmonary preinvasive lesion, minimally and invasive adenocarcinoma presented as ground glass nodules[J]. Lung Cancer, 2017, 108：192-197.
|
| 34 |
Li G, Wu F, Yang H, et al. MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2[J]. Biomed Pharmacother, 2017, 96: 1170-1178.
|
| 35 |
Naito M, Aokage K, Saruwatari K, et al. Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung[J]. Lung Cancer, 2016, 100: 53-62.
|
| 36 |
Koshikawa N, Giannelli G, Cirulli V, et al. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5[J]. J Cell Biol, 2000, 148(3): 615-624.
|
| 37 |
Song X, Chen Q, Wang J, et al. Clinical and prognostic implications of an immune-related risk model based on TP53 status in lung adenocarcinoma[J]. J Cell Mol Med, 2022, 26(2): 436-448.
|
| 38 |
Yim J, Zhu L C, Chiriboga L, et al. Histologic features are important prognostic indicators in early stages lung adenocarcinomas[J]. Mod Pathol, 2007, 20(2): 233-241.
|
| 39 |
Sholl LM, Yeap BY, Iafrate AJ, et al. Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers[J]. Cancer Res, 2009, 69(21): 8341-8348.
|
| 40 |
Soh J, Toyooka S, Ichihara S, et al. Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung[J]. J Thorac Oncol, 2008, 3(4): 340-347.
|
| 41 |
Yatabe Y, Takahashi T, Mitsudomi T. Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer[J]. Cancer Res, 2008, 68(7): 2106-2111.
|
| 42 |
戴书华，刘国芳，向东生. 肺磨玻璃结节CT值测量在早期癌症诊断中的意义[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(6): 770-771.
|